[1] 中国抗癌协会. 肝门部胆管癌规范化诊治专家共识(2015)[J]. 中华肝胆外科杂志, 2015, 21(008):505-511.
[2] 郑树国,项灿宏,冯晓彬,董家鸿.肝门部胆管癌诊断和治疗指南(2013版)[J].中华外科杂志,2013,51(10):865-871.
[3] Ikeyama T, Nagino M, Oda K, et al.Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases[J]. Ann Surg, 2007, 246(6):1052-1057.
[4] Kawasaki S, Imamura H, Kobayashi A, et al.Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization[J]. Ann Surg, 2003, 238(1):84-92.
[5] Nagino M, Kamiya J, Nishio H, et al.Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up[J]. Ann Surg, 2006, 243(3):364-372.
[6] 黄鑫,王良,张跃伟,等. 围肝门切除联合左三区切除治疗BismuthⅣ型肝门部胆管癌[J]. 岭南现代临床外科,2021,21(1):17-22.
[7] 二村雄次. 要点与盲点[M]. 北京:人民卫生出版社, 2013: 298-301.
[8] Kuboki Satoshi,Shimizu Hiroaki, Ohtsuka Masayuki, et al. Incidence, risk factors,management options for portal vein thrombosis after hepatectomy: a 14-year, single-center experience[J]. Am J Surg, 2015, 210: 878-885.e2. |
